Are Investors Undervaluing BioLife Solutions, Inc. (NASDAQ:BLFS) By 30%?
BioLife Solutions Inc (BLFS) Q2 2024 Earnings Call Highlights: Navigating Challenges With ...
Express News | BioLife Solutions Inc : TD Cowen Raises Target Price to $28 From $26
H.C. Wainwright Initiates BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $29
BioLife Solutions: A 'Buy' Rating for Its Strategic Positioning in the Expanding CGT Market
Biolife Solutions CFO Sells Shares Worth Over $35k
Biolife Solutions Executive Sells Over $17k in Company Stock
This BioLife Solutions Insider Reduced Their Stake By 28%
Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?
Small-cap and Mid-cap Health Care Has Room to Rally - Roth MKM
BioLife Solutions (BLFS) Surpassed Revenue and Earnings-Per-Share Expectations in Q2
BioLife Solutions, Inc. (NASDAQ:BLFS): Is Breakeven Near?
Express News | BioLife Solutions Inc : Benchmark Raises Target Price to $30 From $25
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $30
Maxim Group analyst Jason McCarthy maintains $BioLife Solutions(BLFS.US)$ with a buy rating, and sets the target price at $30.According to TipRanks data, the analyst has a success rate of 21.6% and
Buy Rating Affirmed for BioLife Solutions Amid Strong Market Position and Positive Financial Outlook
Craig-Hallum Maintains Buy on BioLife Solns, Raises Price Target to $30
Express News | BioLife Solutions Inc : Stephens Raises Target Price to $30 From $27
BioLife Solutions, Inc.'s (NASDAQ:BLFS) 31% Jump Shows Its Popularity With Investors
Earnings Call Summary | BioLife Solutions(BLFS.US) Q2 2024 Earnings Conference
BioLife Solutions, Inc. (BLFS) Q2 2024 Earnings Call Transcript